Redaccin Farmacosalud.com Eli Lilly and Company comunica resultados positivos del ensayo clnico de fase 3 SUMMIT, que evala la seguridad y eficacia de tirzepatida inyectable (5 mg, 10 mg o 15 mg) en adultos con insuficiencia cardaca con fraccin de eyeccin preservada (ICFEp) y obesidad
Lets all advocate for semaglutide as comparator
Her timing proved fortunate: "I was very lucky and downloaded the savings coupon in August of 2022, when the terms and conditions were still allowing people to get the medication when it wasn't covered by insurance at only $25 a month." Like most patients, she began at the lowest dose
This study recruited 1382 African-Americans from the University of Texas Southwestern Medical School in Dallas and 91 patients from the Ben Taub Hospital, Houston
Patients benefit from direct access without membership fees, no insurance requirement, and HSA/FSA eligibilityproviding the same tax-advantaged savings available through many health plans
Anti-Obesity Medications are never used when pregnant or breastfeeding and some can cause birth defects, so we advise prevention of pregnancy while on an Anti-Obesity Medications